Culture & Values

Our commitment is driven by our focus on five key elements essential to the success of our business — people, passion, performance, pride, and a steadfast commitment to delivering on our promises.

Print

Culture & Values

Enzon is committed to the development of therapeutics to treat cancer and other life-threatening diseases. Our commitment is driven by a set of corporate values that focus on five key elements essential to the success of our business: people, passion, performance, pride, and a steadfast commitment to delivering on our promises. These values describe who we are, how we conduct ourselves, and are founded upon a commitment to excellence.

People

Our employees are the foundation of our business. We are committed to cultivate an environment that attracts, motivates, and develops individuals who are committed to playing an active role in our success as a company. We respect the importance of the individual but also recognize the remarkable potential and strength of a unified team.

Passion

We are passionate about advancing our common goal of bringing innovative products to the marketplace to improve patient care. We have a “can do” attitude and believe in transforming possibilities into realities. We believe in ourselves, believe in Enzon’s potential, and want to be a major part of maximizing that potential.

Performance

We are committed to maintaining a high-performance culture that is focused on the long-term success of Enzon. We strive for our performance to exceed the expectations of everyone we deal with in our jobs — both internally and externally. We take initiative to work independently and together to seize opportunities, indentify solutions, and overcome challenges.

Pride

We take pride in maintaining high standards of quality in all that we do. We are dedicated to the people who depend on our business and our products.

Promises

We believe that promises that are made must be delivered — as the success of our business rests upon our trustworthiness. We are honest and accountable for our actions.

Search
(ENZN) NASDAQ
Last Trade9.82
Change(%)price+0.01
Volume261232
News
  • 09-10-2009

    Enzon to Present at NewsMakers...

    Enzon to Present at NewsMakers in the Biotech Industry Conference

    click here for more information

  • 07-27-2009

    Enzon to Release Second Quarte...

    Enzon to Release Second Quarter 2009 Earnings on Tuesday, August 4, 2009; Conference Call and Webcast to Follow

    click here for more information

  • 07-27-2009

    Enzon to Present at BMO Focus...

    Enzon to Present at BMO Focus on Healthcare Conference

    click here for more information

  • 07-23-2009

    Enzon Enhances Governance with...

    Enzon Enhances Governance with the Addition of a New Non-Executive Chairman and New Independent Director

    click here for more information

  • 04-23-2009

    Enzon's Board of Directors Rea...

    Enzon's Board of Directors Reaffirms Support of its Chairman and CEO

    click here for more information

  • 02-10-2009

    Enzon Discontinues Further Dev...

    Enzon Discontinues Further Development of rhMBL

    click here for more information

  • 11-05-2008

    Enzon Reports Solid Third Quar...

    Enzon Reports Solid Third Quarter 2008 Results
    -- Provides update on the sale of the specialty pharma business --

    click here for more information

  • 10-27-2008

    Enzon's HIF-1 alpha Antagonist...

    Enzon's HIF-1 alpha Antagonist Shows Antitumor Activity
    --Innovative and diverse pipeline advances--

    click here for more information

  • 07-27-2009

    Enzon to Release Second Quarte...

    Enzon to Release Second Quarter 2009 Earnings on Tuesday, August 4, 2009; Conference Call and Webcast to Follow

    click here for more information

  • 01-28-2009

    Enzon Nominates Two New Candid...

    Enzon Nominates Two New Candidates for its Board of Directors

    click here for more information

  • 10-27-2008

    Enzon's HIF-1 alpha Antagonist...

    Enzon's HIF-1 alpha Antagonist Shows Antitumor Activity
    --Innovative and diverse pipeline advances--

    click here for more information

  • 04-30-2008

    Enzon to Release First Quarter...

    Enzon to Release First Quarter 2008 Earnings on Wednesday, May 7, 2008; Conference Call and Webcast to Follow

    click here for more information